Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.

Literature DB >> 11465725

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.

Y Kawaguchi¹, H Terajima, M Harigai, M Hara, N Kamatani.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Biomarkers
Interleukin-18

Year: 2001 PMID： 11465725 DOI： 10.1002/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I

Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591

Keyword Cloud
Cited

× No keyword cloud information.

30 in total

Review 1. Diagnosis and management of adult onset Still's disease.

Authors: P Efthimiou; P K Paik; L Bielory
Journal: Ann Rheum Dis Date: 2005-10-11 Impact factor: 19.103

Review 2. The use of anakinra in juvenile arthritis.

Authors: Andreas Reiff
Journal: Curr Rheumatol Rep Date: 2005-12 Impact factor: 4.592

Review 3. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.

Authors: Ryota Sakai; Hayato Nagasawa; Eiko Nishi; Ayumi Okuyama; Hirofumi Takei; Takahiko Kurasawa; Tsuneo Kondo; Koji Nishimura; Yuichiro Shirai; Tatsuya Ito; Hideto Kameda; Tsutomu Takeuchi; Koichi Amano
Journal: Clin Rheumatol Date: 2012-01-04 Impact factor: 2.980

4. Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.

Authors: R Sighart; J Rech; A Hueber; N Blank; S Löhr; A Reis; H Sticht; U Hüffmeier
Journal: Rheumatol Int Date: 2017-11-20 Impact factor: 2.631

5. Cutaneous manifestations associated with adult-onset Still's disease: important diagnostic values.

Authors: Toshiyuki Yamamoto
Journal: Rheumatol Int Date: 2011-12-25 Impact factor: 2.631

6. The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.

Authors: Kuo-Tung Tang; Chia-Wei Hsieh; Hsin-Hua Chen; Yi-Ming Chen; Shih-Hsin Chang; Po-Hao Huang; Joung-Liang Lan; Der-Yuan Chen
Journal: Clin Rheumatol Date: 2021-09-17 Impact factor: 2.980

7. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.

Authors: Xia Chen; Qiong-Yi Hu; Mengyan Wang; Jinchao Jia; Jialin Teng; Yue Sun; Xiaobing Cheng; Junna Ye; Yutong Su; Hui Shi; Huihui Chi; Zhuochao Zhou; Tingting Liu; Zhihong Wang; Liyan Wan; Xin Qiao; Fan Wang; Xinyao Wu; Chengde Yang; Hong-Lei Liu
Journal: Rheumatol Int Date: 2021-09-09 Impact factor: 2.631